Squarepoint’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-45,054
Closed -$330K 3070
2025
Q1
$330K Buy
+45,054
New +$330K ﹤0.01% 2145
2024
Q4
Sell
-22,478
Closed -$196K 3095
2024
Q3
$196K Sell
22,478
-42,433
-65% -$369K ﹤0.01% 2180
2024
Q2
$444K Buy
64,911
+47,614
+275% +$326K ﹤0.01% 1787
2024
Q1
$157K Buy
17,297
+3,353
+24% +$30.5K ﹤0.01% 2160
2023
Q4
$62.2K Buy
+13,944
New +$62.2K ﹤0.01% 2343
2023
Q3
Sell
-13,689
Closed -$70.6K 2729
2023
Q2
$70.6K Buy
+13,689
New +$70.6K ﹤0.01% 2256
2022
Q4
Sell
-17,291
Closed -$72K 2529
2022
Q3
$72K Sell
17,291
-19,600
-53% -$81.6K ﹤0.01% 1924
2022
Q2
$148K Buy
+36,891
New +$148K ﹤0.01% 1808
2021
Q4
Sell
-19,913
Closed -$199K 2734
2021
Q3
$199K Sell
19,913
-14,768
-43% -$148K ﹤0.01% 1829
2021
Q2
$492K Buy
34,681
+14,655
+73% +$208K ﹤0.01% 1615
2021
Q1
$329K Buy
20,026
+9,711
+94% +$160K ﹤0.01% 1817
2020
Q4
$214K Sell
10,315
-106,531
-91% -$2.21M ﹤0.01% 2091
2020
Q3
$889K Sell
116,846
-32,411
-22% -$247K 0.01% 1008
2020
Q2
$1.24M Buy
149,257
+123,833
+487% +$1.03M 0.02% 824
2020
Q1
$126K Buy
+25,424
New +$126K ﹤0.01% 1588
2019
Q4
Sell
-14,348
Closed -$44K 2589
2019
Q3
$44K Buy
+14,348
New +$44K ﹤0.01% 2148
2018
Q1
Sell
-22,243
Closed -$99K 1999
2017
Q4
$99K Buy
+22,243
New +$99K ﹤0.01% 1952
2017
Q3
Sell
-15,703
Closed -$146K 1787
2017
Q2
$146K Buy
+15,703
New +$146K ﹤0.01% 1356
2017
Q1
Sell
-60,985
Closed -$510K 1798
2016
Q4
$510K Buy
+60,985
New +$510K 0.02% 816